ABSTRACT (250 words) 23
Over the last decade a new strategy was developed to bypass the difficulties to genetically 24 engineer some microbial species by transferring (or "cloning") their genome into another 25 organism that is amenable to efficient genetic modifications and therefore acts as a living 26 workbench. As such, the yeast Saccharomyces cerevisiae has been used to clone and engineer 27 genomes from viruses, bacteria and algae. The cloning step requires the insertion of yeast 28 genetic elements within the genome of interest, in order to drive its replication and 29 maintenance as an artificial chromosome in the host cell. Current methods used to introduce 30 these genetic elements are still unsatisfactory, due either to their random nature (transposon) 31 or the requirement for unique restriction sites at specific positions (TAR cloning). Here we 32 describe the CReasPy-Cloning, a new method that combines both the ability of Cas9 to cleave 33 DNA at a user-specified locus and the yeast's highly efficient homologous recombination to 34 simultaneously clone and engineer a bacterial chromosome in yeast. Using the 0.816 Mbp 35 genome of Mycoplasma pneumoniae as a proof of concept, we demonstrate that our method 36 can be used to introduce the yeast genetic element at any location in the bacterial 37 chromosome while simultaneously deleting various genes or group of genes. We also show 38 that CReasPy-cloning can be used to edit up to three independent genomic loci at the same 39 time with an efficiency high enough to warrant the screening of a small (<50) number of 40 clones, allowing for significantly shortened genome engineering cycle times. 41
INTRODUCTION (750 words) 48
Genetically engineering a living organism is a key technology, for both fundamental and 49 applied purposes. The ability to specifically delete, replace or add a sequence to a genome can 50 be used to study the function of a given gene or group of genes 1 , or to add new or improved 51 functions to a cell 2 . 52
From early groundbreaking experiments on bacterial transformation 3 , to the most recent 53 advances in genomic engineering using targetable nucleases 4,5 , a wide array of tools have 54 been developed in order to introduce and maintain exogenous genetic material in an organism 55 or to directly edit the existing genome. However, while multiple strategies are often available 56
for the majority of model organisms, many species of biological interest still lack efficient 57 genetic engineering tools 6 . 58
Over the last decade, it was proposed that these difficulties could be bypassed by transferring 59 a whole genome to edit it into another cell where efficient tools are available 7 . This approach 60 was in particular developed using the yeast Saccharomyces cerevisiae as a genetic workbench 61 to manipulate whole bacterial chromosomes. This process was also applied for the creation of 62 the first bacterial cell governed by a chemically synthesized genome 8 and the smallest 63 engineered living organism 9 . 64
Given the large array of genetic tools available in yeast, including TREC 10 , TREC-IN 11 , 65 CRISPR-Cas9 12,13 , this genome engineering strategy has generated a growing interest. To this 66 date, a wide range of chromosomes from different organisms have been successfully cloned in 67 yeast, originating from viruses 14,15 , bacteria 16,17 and algae 18 . 68
In order to clone a bacterial chromosome in yeast, several elements must be added to it. These 69 "yeast elements" are: a yeast origin of replication, a yeast centromere and a selection marker. 70
All these elements are required to drive the replication and maintenance of the foreign DNA, 71 and are usually provided as a single cassette that can be inserted into the bacterial genome 72 using two main strategies. The first one relies on an initial transformation of the bacteria with 73 a transposon bearing the yeast elements 7 . While selection of living transformants ensures that 74 the random integration of the transposon has not occurred in any locus essential for in-vitro 75 growth, this method cannot be used to integrate the yeast elements at a specific position of the 76 genome. The second strategy is based on the Transformation-Associated Recombination 77 (TAR) cloning technique 19 . The complete bacterial genome is isolated in agarose plugs, 78 linearized by restriction, and co-transformed into yeast together with the yeast element 79 cassette flanked by recombination arms corresponding to both sides of the restriction locus. 80
The yeast homologous recombination mechanism then circularize the bacterial chromosome 81 4 by integration of the cassette. This approach necessitates the presence of a unique restriction 82 site in the bacterial genome, preferably in a non-essential locus, which can be hard to find and 83 limits the number of integration sites available. 84
In this study, we have developed a new strategy called CReasPy-Cloning, in order to 85 efficiently insert the yeast elements at any desired locus of a DNA fragment to be cloned in 86 yeast. This method expands on the logic of TAR cloning, by using the CRISPR/Cas9 system 87 to generate a double strand break at a precise site of the genome to clone. In addition, the 88 flexibility offered by the choice of the insertion locus allows us to simultaneously perform the 89 cloning and edition of a bacterial genome. 90
To demonstrate the effectiveness of the CREASPY-cloning strategy, we cloned with a high 91 efficiency the genome of Mycoplasma pneumoniae M129 20 in yeast, while simultaneously 92 deleting a gene encoding for a virulence factor. Analysis showed that the cloned genome was 93 intact and essentially error-free. We successfully applied the same strategy to Mycoplasma 94 leachii strain PG50 21 , in order to demonstrate that genomes cloned using CREASPY-cloning 95 are suitable for genome transplantation. We then stretched the capability of CREASPY-96 cloning by successfully editing two or three distinct loci simultaneously. 97
98

RESULTS AND DISCUSSION 99
Simultaneous cloning and engineering of Mycoplasma pneumoniae genome in yeast 100
We have developed a method dubbed "CReasPy-cloning", in order to perform the 101 simultaneous cloning and engineering of megabase-sized genomes in yeast. Figure 1A  102 outlines the general principle of the method. First, the yeast Saccharomyces cerevisiae strain 103 VL6-48N is transformed with the plasmids pCas9 and pgRNA, allowing respectively the 104 expression of a codon-optimized version of the Cas9 nuclease from Streptococcus pyogenes 12 105 and a chimeric guide RNA (gRNA) merging the CRISPR RNA with the trans-activating 106 crRNA 12,13,22,23 . Then, the yeasts are co-transformed with the purified bacterial chromosome 107 and a linear DNA cassette comprised of the CEN-HIS yeast elements 7 (CEN: centromere; 108 HIS: histidine auxotrophic marker), an antibiotic resistance marker (used for an eventual back 109 transplantation experiment later on 24 ) and flanked with recombination arms corresponding to 110 the locus to edit ( Figure S1 ). The Cas9/gRNA complex generates a double strand break at the 111 targeted locus on the bacterial chromosome, which is then repaired by the homologous 112 recombination machinery of the yeast using the provided template cassette. As a result, the 113 target locus is edited, and the bacterial genome now bears the CEN-HIS elements and is 114 carried by the yeast as a large centromeric plasmid. After the CReasPy-cloning protocol, the 115 5 yeast transformants are screened using a combination of PCR analysis and chromosome size 116 determination by PFGE, in order to check the integrity of the cloned genome. 117
As a proof of concept, we have used CReasPy-cloning to simultaneously clone and engineer 118 the genome of the human pathogen M. pneumoniae M129 (816 kb), for which no efficient 119 genome engineering tool is available. Three genes encoding virulence factors were targeted: 120 MPN372 encoding the CARDS toxin 25 , MPN142 encoding a cytadherence protein 26,27 , and 121 MPN400 encoding an immunoglobulin-binding protein 28 ( Figure 1B and 1C ). In the case of 122 MPN400, we targeted either the single gene or the operon it belongs to (MPN398-400). In the 123 case of MPN142, we targeted either the single gene or part of the operon it belongs to 124 (MPN142-143), as the other genes in the operon (MPN140-141) could be essential 29 . 125
Initially, a set of experiments targeting MPN372 was performed during which all the 126 components (pgRNA, pCas9, chromosome and cassette) were co-transformed simultaneously 127 in the yeast (Table S1 ). However, these experiments failed to yield positive clones. Therefore, 128 an alternative protocol was set up, in which the pgRNA and pCas9 were transformed first, in 129 order to give the yeast cells enough time to express the Cas9 nuclease and its partner gRNA 130 before transformation with the bacterial chromosome. This strategy was much more efficient, 131
and was used for the rest of the experiments described below. 132
First, the CReasPy-cloning was used to clone the M. pneumoniae genome while deleting the 133 MPN372 gene ( Figure 2 ). The presence of the M. pneumoniae genome cloned in yeast and the 134 replacement of the target gene by the repair cassette were detected by simplex PCR. Twenty 135 yeast transformants were screened, and all of them presented the expected profile with a 136 single amplicon at 3,595 bp ( Figure 2A ). In a second step, a multiplex PCR was performed 137 using two sets of 10 primer pairs, targeting a total of 20 loci evenly spread on the 138 chromosome of M. pneumoniae ( Figure S2 ), to check the completeness of the cloned genome. 139 A total of 16 clones out of the 20 tested presented the expected 10 bands profile with both sets 140 of primers ( Figure 2B ). Four clones (6.6, 6.7, 7.5 and 7.8) lacked one or more amplicons in 141 one or both multiplex PCR, indicating that either one or several large parts of the bacterial 142 genome had been lost during the CReasPy-cloning process. The cause of these large deletions 143 in genomes that harbor the repair cassette at the correct location, is currently unknown, but 144 might be linked the documented off-target activity of Cas9 30-32 . Indeed, if the nuclease 145 cleaves the DNA at undesired loci, the yeast would need to perform a homologous 146 recombination between two similar sequences elsewhere in the genome in order to maintain 147 it. This phenomenon could be bolstered by the effective presence of multiple repeated regions 148 in the genome of M. pneumoniae [33] [34] [35] . The final transformants screening was based on the 149 6 analysis of large DNA fragments generated by enzymatic restriction of the edited 150 chromosome followed by PFGE. Among the 16 yeast clones validated by multiplex PCR, six 151 were randomly selected and checked ( Figure 2C ). Five clones presented the expected profile, 152 identical to that of the non-edited genome, with two fragments at 711 kbp and 105 kbp, for a 153 chromosome size of 816 kbp. 154
In order to demonstrate the robustness of the CReasPy-cloning editing method, the same 155 process was applied for the targeted deletions listed in Table 1 . For the deletions MPN400 156 and MPN398-400, 100% of the 20 tested clones were found positive by simplex PCR. When 157 we targeted the MPN142 and MPN142-143 regions, 95% and 80% of the screened clones had 158 the expected simplex PCR profiles, respectively (Table 1) . At the next step, 79%, 69%, 50% 159 and 70% of the clones validated by simplex PCR were found positive in multiplex PCR, for 160 the deletion of MPN142, MPN142-143, MPN400 and MPN398-400, respectively. Finally, 161 67%, 67%, 83% and 83% of the clones tested by PFGE were positive, for MPN142, 162 MPN142-143, MPN400 and MPN398-400, respectively (Table 1) . 163
Overall, the CReasPy-cloning method we developed exhibits a high efficiency, as only a 164 small number of clones (around 20) have to be screened to identify those carrying the 165 expected edited bacterial chromosome. Using a yeast elements cassette which does not 166 contain an Autonomously Replicating Sequence 36 (ARS) was identified as a key factor in 167 reaching this high efficiency. The ARS acts as an origin of replication for the artificial yeast 168 chromosome 7 and must contain a copy of the essential 11 bp ARS Consensus Sequence: 5'-169 WTTTAYRTTTW-3'. It has been reported that removing the ARS sequence from TAR vector 170 increased the efficiency of transformation 37 . This improvement was linked to the fact that the 171 recombination template tends to circularize instead of integrating into the bacterial 172 chromosome during yeast transformation. This circular element bearing the ARS sequence is 173 efficiently replicated in yeast, leading to false-positive clones. In our case, the removal of the 174 ARS sequence did not jeopardize the replication of the M. pneumoniae chromosome by the 175 yeast machinery, as the 11 bp ARS Consensus Sequence is present 19 times in the bacterial 176 genome. During an initial experiment, we performed CReasPy-cloning experiment with an 177 ARS-containing or an ARS-less recombination template (Table S2) , and obtained better 178 results with the latter. 179
In addition, several other genome cloning experiments were also performed in the yeast S. 180 cerevisiae strain W303a, as this strain and the strain VL6-48N were both used in previous 181 studies focused on the cloning and edition of mycoplasma genomes in yeast 7,38,39 . Overall, 182 7 similar transformation efficiencies were obtained for both strains (data not shown We observed that the cloning efficiencies of Mmm and M. leachii genomes (Table 2) The multi-target protocol is based on the same principle as the single-target CReasPy-cloning, 231 with few modifications (Figure 3) . First, the yeasts are "primed" by transformation with 232 pCas9 and a multi-guide pgRNA. To reduce the possibility of off-target cleavage by the Cas9 233 nuclease, we elected to use the mutant eSpCas9 which was shown to have a higher 234 specificity 42 than the wild-type. Afterwards, the cells are co-transformed with M. pneumoniae 235 chromosome and 2 or 3 recombination templates. One of the template contains the CEN-HIS 236 yeast elements, while the other or other two are clean deletion cassettes comprised of two 237 juxtaposed 500 bp regions identical to the loci surrounding the gene to delete. These cassettes 238 are tedious to produce (here by overlap PCR), but the large size of their recombination arms 239 have a positive impact on the recombination efficiency 37 , which offset the lack of a selection 240 marker. Alternatively, 2x45 bp deletion cassettes, easily produced by annealing of two 90 bp 241 oligonucleotides, can be used and have been shown to be efficient to engineer the genome of 242 S. cerevisiae 12 or to edit a mycoplasma genome cloned in S. cerevisiae 13 . After the multi-243 target CReasPy-cloning, yeast transformants were screened using the same process as in the 244 single-target protocol. 245 Figure 4 illustrates an example of screening for the triple deletion 246 MPN372*/MPN142/MPN400. Twenty yeast clones were first checked by simplex PCR for 247 the deletion of MPN372 and its replacement by the yeast elements cassette ( Figure 4A) , 248 which yielded 14 positive clones with the expected amplicon at 3,596 bp. These positive 249 clones were subsequently screened by PCR for the deletion of MPN142 ( Figure 4B ), yielding 250 9 four positive clones presenting the expected 965 bp band. Finally, the deletion of MPN400 251 was assessed ( Figure 4C ), resulting in three positive clones presenting the expected 2,156 bp 252 band. The three clones obtained for the triple deletion were successfully validated by 253 multiplex PCR ( Figure 4D ) and PFGE ( Figure 4E) . 254
All the multi-target deletions tested yielded positive clones (Table 3) . As expected, due to the 255 large number of co-transformed DNA fragments, the efficiency of the multi-target approach is 256 significantly lower than that of the single-target CReasPy-cloning. Nonetheless, this 257 efficiency is still high enough (minimum of 5% of the screened clones are fully validated) to 258 warrant the screening of a relatively small set of transformants (i.e. <50). It is interesting to 259 note that the majority of the negative simplex PCR showed no amplification instead of 260 amplification of the wild-type locus, suggesting that the targeted region is absent of the final 261 chromosome. This high rate of unwanted deletions could be caused by the stochastic nature of 262 the transformation process. Indeed, for the CReasPy-cloning process to occur properly, each 263 cell must receive at least one copy of each recombination template. As there is a low 264 probability of this perfect-case scenario to occur, many cells will lack one or more templates. 265
As a result, the transformed chromosome will be cleaved at the desired site, but in the absence 266 of a template the recombination will happen in a spurious manner between similar loci. This 267 suggests that, although possible in theory, stretching the CReasPy-cloning strategy to four or 268 five targets might not be practical. Nonetheless, the ability to simultaneously clone a 269 megabase-sized genome and edit three individual loci is still a significant improvement over were also identified in the genome of clone 4.8, suggesting that they occurred before the 288 CReasPy-cloning process. Two additional mutations that were found only in clone 4.8. The 289 first is an AAG to AAU transversion at position 182216 of the genome, leading to a K to N 290 amino acid change in MPN141 (adhesin P1). The second is an insertion of ATGTTTG at 291 position 452508 of the genome, in a region predicted to encode the ncRNA MPNnc041. The 292 extent of the mutations observed in clone 4.8 suggest that the CReasPy-cloning method has 293 no large mutagenic effect. However, SNP were expected as a result of natural genetic drift 294 during the passages of either the mycoplasma or yeast cells in the laboratory. 295 296
In vitro CReasPy-Cloning 297
In order to improve the flexibility of the CReasPy-cloning process, we attempted to perform 298 the chromosome cleavage step in vitro ( Figure S7 ). Indeed, this alternative strategy could 299 offer several benefits compared to the in vivo method described above: i) it would not be 300 necessary to "prime" the yeast with the pgRNA and pCas9 plasmids, reducing the number of 301 transformation steps to one, ii) the selection markers used to maintain the pgRNA and pCas9 302 plasmids could be allocated for other purposes, iii) a large number of different gRNA could 303 be used simultaneously without the need to build a complex multi-gRNA plasmid, iv) the host 304 cell genome could not be damaged by off-target activity, as the nuclease is not present in the 305 cell. To do so, agarose plugs containing M. pneumoniae chromosomes were incubated in a 306 mix of recombinant Cas9 from S. pyogenes and gRNA expressed by in vitro transcription 307 from oligonucleotides. The Cas9-gRNA complex is able to diffuse through the agarose matrix 308 and cleave the chromosome at the target site. The cut chromosome was subsequently co-309 transformed in yeast together with a recombination cassette bearing the yeast elements. 310
We validated this in vitro CReasPy-cloning strategy by targeting MPN400, using the same 311 recombination cassette and gRNA spacer as those used in the in vivo approach. Ten yeast 312 transformants were subsequently screened as described above ( Figure S8 ): all the checked 313 clones were positive by simplex PCR, and four were positive by multiplex. Of these, three 314 were validated by PFGE. 315
These results confirm the functionality of the in vitro approach, albeit with a slightly reduced 316 efficiency compared to the in vivo strategy. Similar strategies, based on in vitro cleavage of 317 DNA by CRISPR/Cas9 followed by capture in yeast have been highlighted by other 318 groups 43,44 but these approaches are currently limited to sizes below 150 kbp and are not 319 suitable to work on whole bacterial genomes.To go on further, optimization of multiple 320 parameters could be considered, including the concentration of Cas9 and gRNA, the 321 incubation time and the amount of target chromosomes per agarose plug. 322 323 CONCLUSION 324
In this study, we developed the CReasPy-cloning tool, to efficiently clone megabase-sized 325 DNA molecules in S. cerevisiae, while simultaneously editing up to three independent loci. 326
This approach was originally conceived in order to improve the cloning process of bacterial 327 genomes, in particular of the genus Mycoplasma, and to significantly shorten the time 328 necessary to produce highly engineered strains for academic or applied purposes 45 . 329
However, our method is not limited to this type of application, as its reliance on the 330 CRISPR/Cas9 system and homologous recombination makes it highly versatile and able to 331 process DNA from different origins and of various sizes, as the entire genomes of some 332 viruses, bacteria, chloroplasts and mitochondria or parts of more complex genomes as those 333 of eukaryotic cells. 334
In particular, we propose that CReasPy-cloning could be a valuable tool to capture intact 335 chromosomes of uncultivable microorganisms from environmental samples ( Figure S10) . A 336 target sequence could be selected based on previous or co-occurring metagenomics analysis, 337 even if only small contigs are available. By producing an appropriate gRNA and 338 recombination cassette, the chromosome of interest could in effect be "fished-out" by the 339 yeast from the complex mixture of environmental DNA. Once cloned in yeast, these genomes 340 could be easily sequenced and assembled in a single contig, which might not be possible 341 using shotgun metagenome sequencing for rare organisms 46 . 342
343
METHODS 344
Yeast and bacterial strains, culture conditions 345
Saccharomyces cerevisiae strain VL6-48N (MATa, his3-Δ200, trp1-Δ1, ura3-52, lys2, ade2-346 101, met14) is grown at 30°C in YPDA medium (Clontech). Yeast transformants are selected 347 by growth in Synthetic Defined (SD) medium depleted for one or several amino-acids: SD-348
Trp, SD-His or SD-Trp-Ura (Clontech). All the oligonucleotides used for this study are supplied by Eurogentec and are described in 356 Table S3 . Yeast cells carrying the pCas9 and pgRNA plasmids are transformed as described by 419 Kouprina and Larionov (2008) 19 . For the simple target deletion experiments, 100 µL of yeast 420 spheroplasts are mixed with 2 µg of genomic DNA and 300 ng of recombination template 421 containing the yeast elements. For the multiple target deletion experiments, 100 µL of yeast 422 spheroplasts are mixed with 2 µg of genomic DNA, 300 ng of recombination template 423 containing the yeast elements and 0.5 or 1 µg of each recombination template without the 424 yeast elements. After transformation, the yeast cells are selected on SD-His solid agar plates 425 containing 1 M of sorbitol, for 4 days at 30°C. Individual colonies are picked and streaked on 426 SD-His plates and incubated 2 days at 30°C. Then, one isolated colony per streak is patched 427 on the same medium and incubated for 2 days at 30°C. 428 429
Screening of yeast transformants carrying Mycoplasma genome 430
Total genomic DNA is extracted from yeast transformants according to Kouprina and 431 Larionov (2008) 19 . Positive clones are screened for both the presence of the Mycoplasma 432 genome and the correct deletion of the target gene by PCR, using the Advantage 2 433
Polymerase kit (Clontech) and specific primers located on either side of the target locus. 434
Yeast transformants are then screened for bacterial genome completeness by multiplex PCR 435 using two sets of PCR primers for M. pneumoniae (Table S3 ) and one set of primers for M. 436 leachii and for Mmm (Table S4 and S5 respectively). Each set is comprised of ten pairs of 437 primers evenly distributed across the bacterial genomes allowing the simultaneous 438 amplification of ten fragments ranging from ~100 to ~1000 bp, in ~100 bp increment. Clones 439 carrying mycoplasma genomes with no major rearrangements display a characteristic ten 440 bands ladder-profile with each primer set. The multiplex PCR are performed using the Qiagen 441
Multiplex PCR Kit according to the manufacturer's instructions. 442 
